SERPINF1 and pancreatic neoplasm: Further studies are necessary to identify signaling pathway(s) and cell type(s) mediating the anti-tumorigenic effects of PEDF in pancreatic cancer, highlighting the impact of PEDF on both parenchymal and mesenchymal cell compartments during pancreatic cancer progression.